603122 Stock Overview
Cowealth Medical China Co.,Ltd. distributes medical products in the Greater China market.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Cowealth Medical China Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.06 |
| 52 Week High | CN¥11.30 |
| 52 Week Low | CN¥5.20 |
| Beta | 0.57 |
| 1 Month Change | -10.62% |
| 3 Month Change | -23.48% |
| 1 Year Change | -36.34% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.50% |
Recent News & Updates
Shareholder Returns
| 603122 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 3.9% | 1.7% | 2.1% |
| 1Y | -36.3% | -34.4% | -14.2% |
Return vs Industry: 603122 underperformed the CN Healthcare industry which returned -35.2% over the past year.
Return vs Market: 603122 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 603122 volatility | |
|---|---|
| 603122 Average Weekly Movement | 9.7% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 603122's share price has been volatile over the past 3 months.
Volatility Over Time: 603122's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 240 | Qiongzhi Wang | ch.cowealth.com |
Cowealth Medical China Co.,Ltd. distributes medical products in the Greater China market. The company offers medical products comprising of swelling, immune diagnosis, and biochemical diagnosis equipment.
Cowealth Medical China Co.,Ltd. Fundamentals Summary
| 603122 fundamental statistics | |
|---|---|
| Market cap | CN¥2.41b |
| Earnings (TTM) | CN¥47.19m |
| Revenue (TTM) | CN¥1.09b |
51.1x
P/E Ratio2.2x
P/S RatioIs 603122 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603122 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.09b |
| Cost of Revenue | CN¥870.46m |
| Gross Profit | CN¥222.14m |
| Other Expenses | CN¥174.96m |
| Earnings | CN¥47.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 20.33% |
| Net Profit Margin | 4.32% |
| Debt/Equity Ratio | 5.6% |
How did 603122 perform over the long term?
See historical performance and comparison